Pharmaceutical (TADAWUL:2070) stocks saw brief relief Thursday after U.S. President Donald Trump left drug products off the list of newly announced tariffs. However, industry leaders and analysts ...

As of Monday, the Nasdaq Composite index had tumbled more than 11% since the start of the year. The outlook for the economy ...

Allstate just went shopping and bagged itself $4.16 million worth of Amgen shares—about 15,948 of them, to be exact. Several other investment firms also joined the biotech shopping spree, scooping up ...

Ideaya Biosciences, Inc.'s stock faces pressure from macroeconomic shifts and FDA policies, but remains a buy for savvy ...

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

A federal judge on Friday dismissed a lawsuit that challenged Colorado's power to cap prescription drug costs.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

AstraZeneca’s new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.

A federal judge has dismissed Amgen’s lawsuit against Colorado’s Prescription Drug Affordability Board, allowing the state to move forward with setting price ceilings on prescription drugs, The Denver ...

These are data to week 26 on the monoclonal antibody and antineoplastic agent; data out to week 52 of the MINT trial will be ...

LM Advisors LLC has injected $641,000 worth of confidence into Amgen, scooping up 2,460 shares in Q4. Several other firms ...